Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
TFAP2C-DDR1 axis regulates resistance to CDK4/6 inhibitor in breast cancer.
Journal: Cancer letters
Published: October 01, 2024
Expression of Concern: A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: September 16, 2024
HDAC10 blockade upregulates SPARC expression thereby repressing melanoma cell growth and BRAF inhibitor resistance.
Journal: bioRxiv : the preprint server for biology
Published: December 18, 2023
Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas.
Journal: Cancer cell
Published: June 13, 2023
Trapoxin A Analogue as a Selective Nanomolar Inhibitor of HDAC11.
Journal: ACS chemical biology
Published: March 28, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis.
Journal: Nature communications
Published: August 24, 2022
Reversible lysine fatty acylation of an anchoring protein mediates adipocyte adrenergic signaling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 08, 2021
EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function.
Journal: Cell death & disease
Published: October 01, 2020
Regulation of histone deacetylase activities and functions by phosphorylation and its physiological relevance.
Journal: Cellular and molecular life sciences : CMLS
Published: April 08, 2020
Regulation of poly(a)-specific ribonuclease activity by reversible lysine acetylation.
Journal: The Journal of biological chemistry
Published: January 06, 2020
Last Updated: 09/26/2026